TC BioPharm
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-06-30 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -161 | |
EBITDA | -3,314 | |
EBIT | -3,441 | |
Net Income | -3,321 | 988 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -2,414 | -3,711 |
Cash | 980 | 1,918 |
Basic Shares | 150 | 6,594 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $3,844 | $1,978 | $1,978 |
Gross Profit | 3,844 | 1,978 | 1,978 | |
EBITDA | -13,609 | -11,321 | -6,475 | -5,262 |
EBIT | -14,239 | -12,083 | -7,287 | -6,141 |
Net Income | -5,906 | -1,313 | -13,575 | -5,457 |
Net Change In Cash | 0 | 3,844 | 1,978 | 1,978 |
Free Cash Flow | -10,655 | -15,533 | -5,601 | -3,466 |
Cash | 2,462 | 4,808 | 1,566 | 748 |
Basic Shares | 30 | 3 | 1 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-03-31 | -$27.95 |
2021-12-31 | -$9.36 |
